siRNA therapy reduces triglycerides in patients along with uncommon ailment

.RESEARCH STUDY FEATURE.19 September 2024.

Plozasiran decreased triglyceride amounts by 80% as well as reduced the risk of pancreatitis in people along with constant chylomicronemia, with or without a hereditary diagnosis.